Search Results - "Wang, Ye"

PubPharm (25)

1

Clinicopathological characteristics and prognosis of synchronous brain metastases from non-small cell lung cancer compared with metachronous brain metastases

in: Frontiers in oncology | 2024

by Li, J. | Zhang, X. | Wang, Y. | +3

2

Clinical factors and major pathological response after neoadjuvant chemoimmunotherapy in potentially resectable lung squamous cell carcinoma

in: Frontiers in oncology | 2024

by Wang, Y. | Song, Y. | Wang, R. | +8

3

Volume change rate before and after neoadjuvant systemic therapy of breast cancer is an efficacious evaluation index to predict pathological complete response

in: Frontiers in oncology | 2023

by Xu, Y. | Zhang, W. | Wang, S. | +11

4

Cuproptosis-related risk score predicts prognosis and characterizes the tumor microenvironment in colon adenocarcinoma

in: Frontiers in oncology | 2023

by Wang, J. | Tao, Z. | Wang, B. | +8

5

Editorial : Application and innovation of multiomics technologies in clinical oncology

in: Frontiers in oncology | 2023

by Li, X. | Budzin, A. | Wang, Y.

6

Preoperative prediction model for macrotrabecular-massive hepatocellular carcinoma based on contrast-enhanced CT and clinical characteristics : a retrospective study

in: Frontiers in oncology | 2023

by He, C. | Zhang, W. | Zhao, Y. | +8

7

Heterogenous profiles between primary lung cancers and paired brain metastases reveal tumor evolution

in: Frontiers in oncology | 2023

by Chen, Y. | Dai, X. | Wang, J. | +7

8

Thorax radiotherapy using 18F-positron emission tomography/computed tomography-guided precision radiotherapy is a prognostic factor for survival in patients with extracranial oligometastatic non-small cell lung cancer:A two-center propensity score-matched analysis

in: Frontiers in oncology | 2022

by Liu, C. | Song, Y. | Wang, R. | +9

9

Advances in the Study of CircRNAs in Tumor Drug Resistance

in: Frontiers in oncology | 2022

by Wang, S. | Qian, L. | Cao, T. | +9

10

In 18F-positron emission tomography/computed tomography-guided precision radiotherapy for centrally located non-small cell lung cancer, tumor related atelectasis is a prognostic factor of survival

in: Frontiers in oncology | 2022

by Wang, N. | Qiao, Y. | Song, Y. | +10

1
2
3
Next »
[3]